INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 177 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,927,970 | -22.9% | 133,000 | -6.3% | 0.96% | -13.8% |
Q2 2023 | $8,991,440 | +101.2% | 142,000 | +81.4% | 1.11% | +21.1% |
Q2 2022 | $4,468,000 | +82.5% | 78,277 | +95.7% | 0.92% | +44.3% |
Q1 2022 | $2,448,000 | +156.6% | 40,000 | +33.3% | 0.64% | +124.3% |
Q4 2020 | $954,000 | -62.8% | 30,000 | -70.0% | 0.28% | -63.8% |
Q3 2020 | $2,566,000 | – | 100,000 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
RA Capital Management | 314,349 | $12,587,000 | 1.81% |
WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |